- Home
- KN vs DYN Comparison
KN vs DYN Comparison
Compare KN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KN
- DYN
- Stock Information
- Founded
- KN 1946
- DYN 1984
- Country
- KN United States
- DYN United States
- Employees
- KN N/A
- DYN N/A
- Industry
- KN Consumer Electronics/Appliances
- DYN Medicinal Chemicals and Botanical Products
- Sector
- KN Consumer Staples
- DYN Health Care
- Exchange
- KN Nasdaq
- DYN Nasdaq
- Market Cap
- KN 1.8B
- DYN 1.4B
- IPO Year
- KN N/A
- DYN 2020
- Fundamental
- Price
- KN $18.46
- DYN $8.64
- Analyst Decision
- KN Buy
- DYN Strong Buy
- Analyst Count
- KN 2
- DYN 15
- Target Price
- KN $20.50
- DYN $43.60
- AVG Volume (30 Days)
- KN 571.5K
- DYN 3.7M
- Earning Date
- KN 07-24-2025
- DYN 08-11-2025
- Dividend Yield
- KN N/A
- DYN N/A
- EPS Growth
- KN N/A
- DYN N/A
- EPS
- KN N/A
- DYN N/A
- Revenue
- KN $552,400,000.00
- DYN N/A
- Revenue This Year
- KN $6.49
- DYN N/A
- Revenue Next Year
- KN $5.68
- DYN N/A
- P/E Ratio
- KN $67.74
- DYN N/A
- Revenue Growth
- KN 23.91
- DYN N/A
- 52 Week Low
- KN $12.19
- DYN $6.36
- 52 Week High
- KN $20.86
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- KN 63.97
- DYN 33.82
- Support Level
- KN $17.75
- DYN $8.06
- Resistance Level
- KN $18.59
- DYN $9.30
- Average True Range (ATR)
- KN 0.39
- DYN 0.58
- MACD
- KN 0.03
- DYN -0.13
- Stochastic Oscillator
- KN 86.13
- DYN 21.64
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.